Study of Standardized Withaferin-A for the Treatment of Steroid Refractory Acute Graft Versus Host Disease.

NCT07708987 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

34

Enrollment

OTHER

Sponsor class

Conditions

Hematological Malignancy
GVHD - Graft-Versus-Host Disease
Steriod Refractory

Interventions

DRUG: Standardized Withaferin A (SWA)

Sponsor

Tata Memorial Centre